Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Graminn suppositories
- Development stage
- Unknown
- Lead developer
- INNventa Pharm
- Administration
- Rectal
01
Overview
Graminn suppositories are a rectal medical device developed by INNventa Pharm for the local treatment and relief of symptoms associated with acute and chronic prostatitis, chronic pelvic pain syndrome, hemorrhoids, anal fissures, and anal fistulas. The formulation contains a synergistic combination of active ingredients, including Graminex NAX 7% (a standardized liposoluble rye pollen extract), sodium hyaluronate, common mallow, marigold, aloe vera extracts, clove oil, and vitamins A and E. When applied rectally, the suppositories form a protective lipid and water-absorbing barrier on the mucosal membrane. This barrier provides hydration, reduces inflammation, swelling, and pain, prevents the penetration of pathogens, and accelerates the healing of mucosal erosions and fissures.
- Brand names
- Graminn suppositories
- Other names
- GraminGramin suppositoriesGraminn rectal suppositories
Beyond the preview
Go deeper on Graminn suppositories.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Graminn suppositories.